Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PENG HUANG and PENGXIANG HUANG.
PENG HUANG
Connection Strength
7.432
PENGXIANG HUANG
  1. Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism. Oncotarget. 2016 Nov 01; 7(44):71378-71389.
    View in: PubMed
    Score: 0.588
  2. Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53. Mitochondrion. 2016 Nov; 31:33-39.
    View in: PubMed
    Score: 0.583
  3. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012; 10(5):e1001326.
    View in: PubMed
    Score: 0.431
  4. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol. 2012 Feb 19; 14(3):276-86.
    View in: PubMed
    Score: 0.424
  5. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by ?-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid Redox Signal. 2011 Dec 15; 15(12):2911-21.
    View in: PubMed
    Score: 0.413
  6. Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer. 2011 Aug; 30(8):508-25.
    View in: PubMed
    Score: 0.408
  7. Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity. Cancer Biol Ther. 2011 Jan 15; 11(2):150-6.
    View in: PubMed
    Score: 0.393
  8. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion. 2010 Nov; 10(6):614-25.
    View in: PubMed
    Score: 0.382
  9. Small mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med. 2010 Feb; 31(1):75-92.
    View in: PubMed
    Score: 0.364
  10. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009 Jul; 8(7):579-91.
    View in: PubMed
    Score: 0.351
  11. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxid Redox Signal. 2009 May; 11(5):1083-95.
    View in: PubMed
    Score: 0.349
  12. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta. 2009 May; 1787(5):553-60.
    View in: PubMed
    Score: 0.346
  13. Redox regulation of cell survival. Antioxid Redox Signal. 2008 Aug; 10(8):1343-74.
    View in: PubMed
    Score: 0.332
  14. Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. Antioxid Redox Signal. 2008 May; 10(5):951-61.
    View in: PubMed
    Score: 0.326
  15. The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr. 2007 Jun; 39(3):267-74.
    View in: PubMed
    Score: 0.306
  16. Models of reactive oxygen species in cancer. Drug Discov Today Dis Models. 2007; 4(2):67-73.
    View in: PubMed
    Score: 0.297
  17. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol Pharmacol. 2006 Jul; 70(1):426-33.
    View in: PubMed
    Score: 0.283
  18. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005 Oct 05; 24(19):3482-92.
    View in: PubMed
    Score: 0.272
  19. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin Ther Targets. 2001 Dec; 5(6):697-710.
    View in: PubMed
    Score: 0.209
  20. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science. 2023 09 08; 381(6662):eabn4180.
    View in: PubMed
    Score: 0.059
  21. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018 10; 20(10):1181-1192.
    View in: PubMed
    Score: 0.042
  22. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab. 2018 May 01; 27(5):977-987.e4.
    View in: PubMed
    Score: 0.041
  23. SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents. Cancer Res. 2016 09 15; 76(18):5467-78.
    View in: PubMed
    Score: 0.036
  24. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.035
  25. Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation. Mol Cancer Ther. 2015 Mar; 14(3):788-98.
    View in: PubMed
    Score: 0.032
  26. Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. PLoS One. 2014; 9(7):e101452.
    View in: PubMed
    Score: 0.031
  27. Interleukin-1? promotes ovarian tumorigenesis through a p53/NF-?B-mediated inflammatory response in stromal fibroblasts. Neoplasia. 2013 Apr; 15(4):409-20.
    View in: PubMed
    Score: 0.029
  28. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol. 2006 Dec 18; 175(6):913-23.
    View in: PubMed
    Score: 0.019
  29. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 2005 Dec 15; 65(24):11510-9.
    View in: PubMed
    Score: 0.017
  30. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 2005 Dec 15; 65(24):11658-66.
    View in: PubMed
    Score: 0.017
  31. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002 Oct 04; 111(1):41-50.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.